Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bad Bentheim
Clinical trial register · Germany

Clinical Trials in Bad Bentheim, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie6 Incyte Corporation5 Janssen Research & Development, LLC5 Sanofi4 Takeda4
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Bad Bentheim

60 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic
Apollo Therapeutics Ltd
Phase 2
280
Bad Bentheim, Dresden, Frankfurt, Hamburg, Lübeck, Münster, Witten
2026-05-28
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Munich, Bad Bentheim, Bielefeld, Hamburg, Hanover, Lübeck, Münster, Tübingen
2026-03-09
Recruiting
Takeda
Phase 2
90
Bad Bentheim, Bochum, Mainz, Berlin
2026-01-26
Recruiting
Janssen Research & Development, LLC
Phase 2
240
Bad Bentheim, Berlin, Cottbus, Hamburg, Heidelberg, Mainz, Remscheid, Witten
2026-01-15
Recruiting
Hoffmann-La Roche
Phase 2
120
Bad Bentheim, Hamburg
2026-01-08
Active, closed
UCB Biopharma SRL
Phase 2
165
Bad Bentheim, Leipzig, Mahlow
2025-12-29
Recruiting
Takeda
Phase 3
110
Bad Bentheim, Cologne, Münster, Bonn, Mainz
2025-12-04
Active, closed
Oruka Therapeutics, Inc.
Phase 2
160
Heidelberg, Frankfurt am Main, Bad Bentheim, Kiel
2025-12-03
By invitation
Celldex Therapeutics
Phase 3
1,370
Darmstadt, Dülmen, Kiel, Bad Bentheim, Mainz, Tübingen
2025-11-25
Active, closed
Kymera Therapeutics, Inc.
Phase 2
200
München, Bad Bentheim, Frankfurt, Mainz, Münster
2025-11-24
Recruiting
UCB Biopharma SRL
Phase 3
320
Ahaus, Bad Bentheim, Berlin, Bielefeld, Bochum, Dresden, Göttingen, Kiel
2025-11-14
Active, closed
A Study With CIT-013 in HS Patients
NCT06993233Hidradenitis Suppurativa (HS)
DrugsCIT-013 medium·CIT-013
Citryll BV
Phase 2
108
Bad Bentheim, Bochum, Dresden, Frankfurt, Kiel, Oldenburg
2025-10-31
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Freiburg im Breisgau, Langenau, Mahlow, Hamburg, Bad Bentheim, Münster, Mainz, Quedlinburg
2025-09-22
Recruiting
LEO Pharma
Phase 2
135
Bad Bentheim, Dresden, Göttingen, Hamburg, Kiel, Lübeck, Manheim, Münster
2025-09-11
Active, closed
Bluefin Biomedicine, Inc.
Phase 2
225
Bad Bentheim, Berlin, Göttingen, Heidelberg, Münster
2025-07-15
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Halle, Augsburg, Bad Bentheim, Berlin, Bielefeld, Bochum, Bramsche, Darmstadt
2025-06-27
Active, closed
Incyte Corporation
Phase 3
159
Bad Bentheim, Bonn, Chemnitz, Dresden, Frankfurt, Göttingen, Kiel, Mainz
2025-06-17
Active, closed
Incyte Corporation
Phase 3
573
Bad Bentheim, Göttingen, Hanover, Kiel, Langenau, Merzig
2025-06-12
Active, closed
Zura Bio Inc
Phase 2
247
Bad Bentheim, Bochum, Darmstadt, Dresden, Hamburg, Heidelberg, München, Münster
2025-05-16
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Frankfurt am Main, Mainz, Bad Bentheim, Dresden, Hamburg, Heidelberg, Magdeburg, Münster
2025-05-16
Recruiting
Apogee Therapeutics, Inc.
Phase 2
350
Heidelberg, Tübingen, Augsburg, München, Blankenfelde-Mahlow, Darmstadt, Frankfurt am Main, Bad Bentheim
2025-05-14
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Augsburg, Bad Bentheim, Berlin, Bonn, Bramsche, Darmstadt, Dresden, Friedrichshafen
2025-04-15
Active, closed
Hoffmann-La Roche
Phase 2
162
Freiburg im Breisgau, Bad Bentheim, Merzig, Chemnitz, Quedlinburg, Hamburg
2025-04-01
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Freiburg im Breisgau, Würzburg, Frankfurt am Main, Düsseldorf, Merzig, Leipzig, Bad Bentheim, Berlin
2025-03-20
Recruiting
Takeda
Phase 3
1,088
Bad Bentheim, Bad Doberan, Ratingen, Leipzig, Berlin, Dresden, Hamburg, München
2025-03-03
Recruiting
Incyte Corporation
Phase 3
600
Aachen, Bad Bentheim, Berlin, Bochum, Bonn, Buxtehude, Darmstadt, Dortmund
2025-02-28
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Bad Bentheim, Berlin, Dresden, Freiburg im Breisgau, Hamburg, Herne, Langenau, Minden
2025-02-21
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Augsburg, Tübingen, Erlangen, Mahlow, Darmstadt, Frankfurt am Main, Bad Bentheim, Bramsche
2025-01-08
Active, closed
Industrial Farmacéutica Cantabria, S.A.
Phase 3
520
Bad Bentheim, Berlin, Bochum, Darmstadt, Dresden, Düsseldorf, Frankfurt, Freiburg im Breisgau
2024-10-17
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
Bad Bentheim, Berlin, Erlangen, Hamburg, Herne, Munich, München
2024-10-15
Active, closed
Incyte Corporation
Phase 3
349
Aachen, Bad Bentheim, Berlin, Dortmund, Halle, Hamburg, Heidelberg, Leipzig
2024-10-10
Active, closed
Takeda
Phase 3
2,099
Blankenfelde-Mahlow, Bad Bentheim, Oldenburg, Dresden, Gera, Hamburg
2024-09-04
Active, closed
AbbVie
Phase 3
699
Erlangen, Bad Bentheim, Münster, Dresden, Berlin
2024-08-19
Active, closed
Celldex Therapeutics
Phase 3
976
Aachen, Bad Bentheim, Berlin, Bonn, Dresden, Düsseldorf, Essen, Hamburg
2024-07-19
Active, closed
AbbVie
Phase 3
1,400
Freiburg im Breisgau, Tübingen, Erlangen, Memmingen, Darmstadt, Bad Bentheim, Rostock, Bochum
2024-06-27
Active, closed
UCB Biopharma SRL
Phase 3
176
Bad Bentheim, Berlin, Bonn, Dresden, Erlangen, Frankfurt am Main, Hamburg, Kiel
2024-06-25
Active, closed
Sanofi
Phase 3
1,541
Augsburg, Bad Bentheim, Hamburg, Kiel, Mainz, Münster, Witten
2024-05-08
Active, closed
Celldex Therapeutics
Phase 2
140
Augsburg, Bad Bentheim, Berlin, Bochum, Erlangen, Frankfurt, Heidelberg, Münster
2024-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Augsburg, Bad Bentheim, Berlin, Bochum, Darmstadt, Dresden, Dülmen, Düsseldorf
2024-03-09
Active, closed
Pfizer
Phase 3
394
Stuttgart, Bad Bentheim, Münster
2024-01-19
Active, closed
AbbVie
Phase 3
614
Erlangen, Munich, Blankenfelde-Mahlow, Bonn, Frankfurt am Main, Bad Bentheim, Münster, Mainz
2023-12-19
Active, closed
Incyte Corporation
Phase 3
450
Bad Bentheim, Berlin, Dresden, Hamburg, Mahlow, Münster
2023-11-27
Active, closed
Nektar Therapeutics
Phase 2
396
Augsburg, Erlangen, Bad Bentheim, Mainz, Leipzig, Berlin, Darmstadt, Frankfurt
2023-11-15
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Bad Bentheim, Berlin, Bonn, Dresden, Dülmen, Düsseldorf, Frankfurt am Main, Freiburg im Breisgau
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Munich, Bad Bentheim, Düsseldorf, Münster, Lübeck, Berlin
2023-10-11
By invitation
Biogen
Phase 3
306
Erlangen, Bad Bentheim, Oldenburg, Münster, Dresden, Halle, Berlin
2023-10-03
Recruiting
Pfizer
Phase 2
340
Bad Bentheim, Mainz, Magdeburg
2023-08-22
Active, closed
AbbVie
Phase 3
1,328
Freiburg im Breisgau, Erlangen, Regensburg, Würzburg, Frankfurt am Main, Bad Bentheim, Bramsche, Düsseldorf
2023-06-21
Active, closed
Sanofi
Phase 2
999
Augsburg, Bad Bentheim, Berlin, Dresden, Münster, Osnabrück, Rostock, Witten
2023-04-03
By invitation
Eli Lilly and Company
Phase 3
333
Darmstadt, Frankfurt am Main, Bad Bentheim, Münster, Dresden
2023-03-09
Recruiting
Eli Lilly and Company
Phase 3
595
Bad Bentheim, Berlin, Dresden, Frankfurt am Main, Hamburg, Mainz, München, Münster
2023-02-27
Active, closed
Almirall, S.A.
Phase 4
447
Augsburg, Bad Bentheim, Bochum, Bonn, Detmold, Dresden, Erlangen, Hamburg
2022-10-24
Active, closed
Eli Lilly and Company
Phase 3
377
Bad Bentheim, Darmstadt, Dresden, Frankfurt, Münster
2022-10-18
Active, closed
Biogen
Phase 2/3
450
Heidelberg, Tübingen, Erlangen, Munich, Regensburg, Würzburg, Bad Bentheim, Buxtehude
2022-09-13
Active, closed
Sanofi
Phase 2/3
1,856
Augsburg, Bad Bentheim, Berlin, Blankenfelde-Mahlow, Dresden, Frankfurt, Gera, Hamburg
2022-08-22
Recruiting
Sanofi
Phase 3
284
Bad Bentheim, Berlin, Frankfurt, Mainz, Münster
2022-02-15
Active, closed
AbbVie
Phase 3
132
Bad Bentheim, Bonn, Münster, Mainz, Dresden, Kiel
2021-07-24
Active, closed
Galderma R&D
Phase 3
500
Aachen, Augsburg, Bad Bentheim, Berlin, Bonn, Darmstadt, Dresden, Düsseldorf
2021-01-11
Active, closed
Galderma R&D
Phase 3
1,700
Aachen, Augsburg, Bad Bentheim, Berlin, Bielefeld, Bonn, Buxtehude, Darmstadt
2019-12-30
Active, closed
LEO Pharma
Phase 2
131
Bad Bentheim, Berlin, Bonn, Erlangen, Frankfurt am Main, München, Münster, Oldenburg
2019-05-29
Rows per page Showing 1–60 of 60
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/bad-bentheim

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 60 of those studies with a site in Bad Bentheim.

How many clinical trials are recruiting in Bad Bentheim?

17 of the 60 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 39 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bad Bentheim), 60 studies
PhaseStudiesRecruitingShare
Phase 337861.7%
Phase 220933.3%
Phase 2/3203.3%
Phase 4101.7%

Most active sponsors

Lead sponsors with the most studies (Bad Bentheim)
Lead sponsorStudiesRecruiting
AbbVie61
Incyte Corporation51
Janssen Research & Development, LLC51
Sanofi41
Takeda43
Celldex Therapeutics30
Eli Lilly and Company31
Novartis Pharmaceuticals32
UCB Biopharma SRL31
Biogen20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.